Towards gene therapy for haemophilia B using primary human keratinocytes
- 1 February 1993
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 3 (2) , 180-183
- https://doi.org/10.1038/ng0293-180
Abstract
Haemophilia B might be permanently cured by gene therapy--the introduction of a correct copy of the factor IX gene into the somatic cells of a patient. Here, we have introduced a recombinant human factor IX cDNA into primary human keratinocytes by means of a defective retroviral vector. In tissue culture, transduced keratinocytes were found to secrete biologically active factor IX and after transplantation of these cells into nude mice, human factor IX was detected in the bloodstream in small quantities for one week. This is the first demonstration of a therapeutic protein reaching the bloodstream from transduced primary keratinocytes. This may have implications for the treatment of haemophilia B and other disorders.Keywords
This publication has 33 references indexed in Scilit:
- Expression of human factor IX in mice after injection of genetically modified myoblasts.Proceedings of the National Academy of Sciences, 1992
- Cloning and Expression of the cDNA for Human γ-glutamyl CarboxylaseScience, 1991
- Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.Proceedings of the National Academy of Sciences, 1991
- Human growth hormone in the blood of athymic mice grafted with cultures of hormone‐secreting human keratinocytesThe FASEB Journal, 1990
- Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.Proceedings of the National Academy of Sciences, 1990
- Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.Proceedings of the National Academy of Sciences, 1990
- Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia BBlood, 1989
- The molecular basis of blood coagulationCell, 1988
- An alternative approach to somatic cell gene therapy.Proceedings of the National Academy of Sciences, 1988
- Expression of an Exogenous Growth Hormone Gene by Transplantable Human Epidermal CellsScience, 1987